Association of fluvoxamine with mortality and symptom resolution among inpatients with covid-19 in uganda: a prospective interventional open-label cohort study

HIGHLIGHTS

  • who: Bruce J. Kirenga from the (UNIVERSITY) have published the research work: Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19 in Uganda: a prospective interventional open-label cohort study, in the Journal: (JOURNAL) of 17/Nov/2022
  • what: The main strength of this study is that the authors provide for the first time, to the knowledge , real-world data on the efficacy and tolerability of fluvoxamine among inpatients with COVID-19 in Africa.

SUMMARY

    The SARS-CoV-2 pandemic has created a tremendous economic and health . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?